Navigating Holiday Travel with Parkinson’s
Reading Time: 4 minutes
Introduction
Traveling during the holidays can be especially challenging for individuals with Parkinson’s disease (PD), due to the symptoms and care considerations associated with the condition. Research into the disease-modifying effects …
Read MoreClozapine in Parkinson’s Psychosis
Reading Time: 2 minutes
IntroductionParkinson’s Disease (PD) is a progressive neurological disorder characterized by both motor and non-motor symptoms. Over half of PD patients eventually develop psychotic symptoms, which significantly impact their quality of …
GLP-1 Agonists in Neurodegeneration
Reading Time: 4 minutes
Introduction
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed the management of type 2 diabetes by helping regulate blood sugar levels and offering protective cardiovascular and renal benefits. Intriguingly, they may also …
Read MoreBarriers in Parkinson’s Disease
Reading Time: 3 minutes
Introduction
Parkinson’s disease (PD) is a neurodegenerative disorder that targets dopamine-producing neurons in the brain’s substantia nigra and basal ganglia, leading to a spectrum of motor and nonmotor symptoms. A growing …
Read MoreBig Data in Parkinson’s Care
Reading Time: 4 minutes
Introduction
The advent of Big Data in healthcare has opened new possibilities for enhancing clinical practices, especially in managing complex diseases like Parkinson’s disease (PD). This literature review explores the existing …
Read More